Search Results - "Chang, Jason P E"

Gender survival differences in hepatocellular carcinoma: Is it all due to adherence to surveillance? A study of 1716 patients over three decades by Liou, Wei‐Lun, Tan, Terence J‐Y., Chen, Kaina, Goh, George B‐B., Chang, Jason P‐E., Tan, Chee‐Kiat

“…Background and Aims Hepatocellular carcinoma (HCC) is one of the commonest causes of cancer‐related death worldwide. Whether gender is an independent factor…”
Get full text

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma by Jin, Yu, Wong, Ye Shen, Goh, Brian K. P., Chan, Chung Yip, Cheow, Peng Chung, Chow, Pierce K. H., Lim, Tony K. H., Goh, George B. B., Krishnamoorthy, Thinesh Lee, Kumar, Rajneesh, Ng, Tze Pin, Chong, Samuel S., Tan, Hwee Huang, Chung, Alexander Y. F., Ooi, London Lucien P. J., Chang, Jason P. E., Tan, Chee Kiat, Lee, Caroline G. L.

“…Hepatocellular carcinoma (HCC) is the fifth most common cancer with high mortality, due to late diagnosis and limited treatment options. Blood miRNAs, which…”
Get full text

A study of 3013 cases of hepatocellular carcinoma: Etiology and therapy before and during the current decade by Lim, Miao‐Shan, Goh, George B‐B, Chang, Jason P‐E, Low, Jee‐Keem, Shelat, Vishalkumar G, Huey, Terence C‐W, Dan, Yock‐Young, Kow, Alfred, Shridhar, Iyer, Tan, Poh‐Seng, Junnarkar, Sameer P, Tan, Chee‐Kiat

“…Background and Aim Hepatocellular carcinoma (HCC) is a significant global problem. With advances in HCC diagnosis and therapy, our hypothesis is that there are…”
Get full text

Virtual monitoring for stable chronic hepatitis B patients does not reduce adherence to medications: A randomised controlled study by Kumar, Rajneesh, Yee, Mei-Ling, Goh, George Bb, Chia, Pei-Yuh, Lee, Hwei-Ling, Xin, X, Teo, Pek Se, Ekstrom, Victoria Sm, Tan, Jin Yt, Cheah, Mark Cc, Wang, Yu T, Chang, Jason Pe, Tan, Chee-Keat, Tan, Hiang Keat, Krishnamoorthy, Thinesh L, Chow, Wan-Cheng

“…Chronic hepatitis B (CHB) remains common in endemic regions, causing significant healthcare burden. Patients with CHB may need to be adherent to nucleoside…”
Get more information

Single centre experience of transjugular liver biopsy in 152 patients by Patel, Ankur, Gogna, Apoorva, Irani, Farah Gillan, Teo, Terence K B, Yeow, Tow Non, Jain, Deepak, Lo, Richard H G, Tay, Kiang Hiong, Tan, Bien Soo, Azhar, Rafay, Chang, Jason P E, Taneja, Manish

“…Liver biopsy is considered the definitive investigation in the diagnosis and management of liver disease. This study describes the experience of performing…”
Get more information

A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90 by Teo, Jin-Yao, Allen, John C, Ng, David C, Choo, Su-Pin, Tai, David W.M, Chang, Jason P.E, Cheah, Foong-Khoon, Chow, Pierce K.H, Goh, Brian K.P

“…Abstract Background Curative liver resection is the treatment of choice for both primary and secondary liver malignancies. However, an inadequate future liver…”
Get full text

A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90 by Teo, Jin-Yao, Allen, Jr, John C, Ng, David C, Choo, Su-Pin, Tai, David W M, Chang, Jason P E, Cheah, Foong-Khoon, Chow, Pierce K H, Goh, Brian K P

“…A curative liver resection is the treatment of choice for both primary and secondary liver malignancies. However, an inadequate future liver remnant (FLR)…”
Get full text

The Impact of Radiation Dose and Tumour Burden on Outcomes in Hepatocellular Carcinoma: 11-Year Experience in a 413-Patient Cohort Treated with Yttrium-90 Resin Microsphere Radioembolisation by Chen, Kaina, Tong, Aaron K.T., Moe, Fiona N.N., Ng, David C.E., Lo, Richard H.G., Gogna, Apoorva, Yan, Sean X., Thang, Sue Ping, Loke, Kelvin S.H., Venkatanarasimha, Nanda Karaddi, Huang, Hian Liang, Too, Chow Wei, Ong, Timothy S.K., Yeo, Eng Xuan, Peh, Daniel Yang Yao, Ng, Ashley W.Y., Yang, Lu, Chan, Wan Ying, Chang, Jason P.E., Goh, Brian K.P., Toh, Han Chong, Chow, Pierce K.H.

“…Introduction: Transarterial radioembolisation (RE) using yttrium-90 (Y-90) microspheres is a widely used locoregional therapy for a broad spectrum of…”
Get full text